Related Experiment Videos
The effect of basic fibroblast growth factor on scarring
1Plastic Surgery and Burns Research Unit, University of Bradford, Bradford, UK.
British Journal of Plastic Surgery
|August 6, 2002
Summary
Basic fibroblast growth factor (FGF-2) may reduce scarring by inhibiting myofibroblast accumulation during wound healing. FGF-2 treatment maintained normal collagen structure and wound strength, unlike control groups.
Area of Science:
- Wound healing research
- Fibroblast biology
- Scarring mechanisms
Background:
- Myofibroblasts are key to wound contraction, persisting in hypertrophic scars.
- Transforming growth factor beta 1 (TGF-beta 1) is linked to excessive scarring and myofibroblast accumulation.
- The role of basic fibroblast growth factor (FGF-2) in scarring is largely unknown.
Purpose of the Study:
- To investigate the effect of FGF-2 on myofibroblast presence and collagen structure during wound healing.
- To compare FGF-2's impact with TGF-beta 1 and control treatments in a rat model.
Main Methods:
- Full-thickness skin incisions were made in rats.
- Wounds were treated with TGF-beta 1, FGF-2, or vehicle, or left unmanipulated.
- Histological, immunohistochemical, and tensiometry analyses were performed over 30 days.
Main Results:
- FGF-2 significantly inhibited the transient increase in granulation-tissue myofibroblasts compared to controls.
- Collagen fiber orientation in FGF-2 treated wounds resembled normal dermis.
- Wound breaking strength was preserved in FGF-2 treated groups.
Conclusions:
- FGF-2 demonstrates a potential anti-scarring effect by modulating myofibroblast differentiation.
- FGF-2 may be a therapeutic target for improving wound healing outcomes and reducing scar formation.